Cargando…

Cardiovascular disease risk stratification in type 2 diabetes

Detalles Bibliográficos
Autores principales:	Esdaile, Harriet, Mayet, Jamil, Hill, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543924/ https://www.ncbi.nlm.nih.gov/pubmed/35892178 http://dx.doi.org/10.1111/dme.14922

Ejemplares similares

High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes
por: Tang, Olive, et al.
Publicado: (2020)

Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients
por: Ren, Jingjing, et al.
Publicado: (2022)

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
por: Gourdy, Pierre, et al.
Publicado: (2023)

Type 1 Diabetes: Disease Stratification
por: Insel, Richard, et al.
Publicado: (2017)

Multi-Trait Genomic Risk Stratification for Type 2 Diabetes
por: Rohde, Palle Duun, et al.
Publicado: (2021)

Cardiovascular risk prediction model and stratification in patients with type 2 diabetes enrolled in a Medicare Advantage plan
por: Caplan, Eleanor O, et al.
Publicado: (2021)

A well validated risk stratification index predicts weak material and fetal outcomes in pregnant women with cardiovascular disease
por: Güner, Ahmet, et al.
Publicado: (2021)

Sharpening focus through wider collaboration: evolving heterogeneity in the bi-directional relationship between cardiovascular disease and COVID-19
por: Kaura, Amit, et al.
Publicado: (2021)

Evidence of Lung Function for Stratification of Cardiovascular Disease Risk
por: Lee, Hwa Mu, et al.
Publicado: (2011)

Risk stratification of atherosclerotic cardiovascular disease in Chinese adults
por: Yang, Xue-Li, et al.
Publicado: (2016)

Glucose lowering does not necessarily reduce cardiovascular risk in type 2 diabetes
por: Bourazana, Angeliki, et al.
Publicado: (2022)

A multimodal approach to cardiovascular risk stratification in patients with type 2 diabetes incorporating retinal, genomic and clinical features
por: Fetit, Ahmed E., et al.
Publicado: (2019)

Carotid intima-media thickness and cardiovascular risk in patients with diabetes mellitus type 2 and chronic kidney disease
por: Kawada, Tomoyuki
Publicado: (2020)

Cardiovascular risk stratification in familial hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2016)

Risk Stratification and Anticoagulation in Low-risk Non-valvular Atrial Fibrillation
por: Arya, Arash
Publicado: (2013)

Risk stratification of primary liver cancer
por: Tan, You-Wen
Publicado: (2022)

Usefulness of Carotid Ultrasonography for Risk Stratification of Cerebral and Cardiovascular Disease
por: Nezu, Tomohisa, et al.
Publicado: (2020)

Cardiovascular diseases in women: a differentiated view and risk stratification
por: de Almeida, Maria Cristina Costa, et al.
Publicado: (2023)

Letter: Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes (Diabetes Metab J 2015;39:498-506)
por: Kim, Mi-Kyung
Publicado: (2016)

Heart rate variability based on risk stratification for type 2 diabetes mellitus
por: Silva-e-Oliveira, Julia, et al.
Publicado: (2017)

Cardiovascular diseases risk evaluation in newly diagnosed type-2 diabetics: An association of novel biomarkers apo proteins and C-peptide
por: Purohit, Purvi
Publicado: (2012)

Should ethnicity be included in cardiovascular risk stratification?
por: Krenning, B. J., et al.
Publicado: (2014)

Cardiovascular Risk Stratification: From Phenotype to Genotype?
por: Bittencourt, Marcio Sommer
Publicado: (2018)

Type 2 Diabetes and Cardiovascular Disease: Reducing the Risk
por: Bartels, David W., et al.
Publicado: (2007)

Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure
por: Öncel, Can Ramazan
Publicado: (2018)

Risk stratification in hospitalized COVID-19 patients
por: Horvath, Angela, et al.
Publicado: (2021)

Non-Linear Heart Rate Variability and Risk Stratification in Cardiovascular Disease
por: Stein, Phyllis K, et al.
Publicado: (2005)

Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: McAnally, Heath B., et al.
Publicado: (2021)

Letter: Diabetic Polyneuropathy and Cardiovascular Complications in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:390-6)
por: Ko, Sun-Hye, et al.
Publicado: (2011)

Machine learning for spatial stratification of progressive cardiovascular dysfunction in a murine model of type 2 diabetes mellitus
por: Durr, Andrya J., et al.
Publicado: (2023)

Early mortality risk stratification after SARS-CoV-2 infection
por: Lundon, D.J., et al.
Publicado: (2021)

Early mortality risk stratification after SARS-CoV-2 infection
por: Lundon, D.J., et al.
Publicado: (2021)

The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors
por: Mancuso, Salvatrice, et al.
Publicado: (2020)

Characterization of data-driven clusters in diabetes-free adults and their utility for risk stratification of type 2 diabetes
por: Yacamán Méndez, Diego, et al.
Publicado: (2022)

Novel conduction-repolarization indices for the stratification of arrhythmic risk
por: Tse, Gary
Publicado: (2016)

Cardiovascular Risks and Risk Stratification in Inflammatory Joint Diseases: A Cross-Sectional Study
por: Yagensky, Vasyl, et al.
Publicado: (2022)

Cell-free DNA as a promising marker for risk stratification of pulmonary embolism
por: Neto-Neves, Evandro M
Publicado: (2013)

Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: Peckham, Alyssa M., et al.
Publicado: (2021)

Degree of Agreement between Cardiovascular Risk Stratification Tools
por: Garcia, Guilherme Thomé, et al.
Publicado: (2017)

Diabetes Mellitus Type 2 and Cardiovascular Diseases-Risk Assessment
por: Avdagic-Terzic, Mirsada, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5cltiu0hh5u2c4qfjdoicdbcce